Clinical Trials Logo

68Ga-FAPI PET/CT clinical trials

View clinical trials related to 68Ga-FAPI PET/CT.

Filter by:
  • None
  • Page 1

NCT ID: NCT05499936 Recruiting - Clinical trials for Metastatic Adenoid Cystic Carcinoma

68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This study was used to study the diagnostic value of 68Ga-FAPI, a novel fibroblast activating inhibitor, in metastatic adenoid cystic carcinoma(ACC)

NCT ID: NCT04778345 Not yet recruiting - Gastric Cancer Clinical Trials

Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer

Start date: March 2021
Phase: N/A
Study type: Interventional

This study aims to explore the value of 68Ga-FAPI PET/CT in the diagnosis of gastric cancer peritoneal carcinomatosis in high-risk patients compared with conventional abdominal enhanced CT and 18F-FDG PET/CT. The patients with gastric adenocarcinoma (cT4/N+/M0-1) will be studied.